Autoinflammatory diseases
What are auto-inflammatory diseases?
GENETIC | PHENOTYPES | ||||||||
Acronyme* | OMIM | Locus | Transmission | Disease** | OMIM | Other names | |||
NLRP3 | NLR pyrin domain containing protein 3 | 606416 | 1q44 | Dominant | CINCA | Chronic Infantile Neurological Cutaneous and Articular Syndrome | 607115 | CAPS3
NOMID |
CIAS1 associated periodic syndrome 3 Neonatal Onset Multisystem Inflammatory Disease |
NLRP3 | NLR pyrin domain containing protein 3 | 606416 | 1q44 | Dominant | DFNA34 | Deafness, autosomal dominant 34, with or without inflammation | 617772 | ||
NLRP3 | NLR pyrin domain containing protein 3 | 606416 | 1q44 | Dominant | FCAS1 | Familial Cold Autoinflammatory Syndrome 1 | 120100 | CAPS1 FCU |
CIAS1 associated periodic syndrome 1 Familial cold urticaria |
NLRP3 | NLR pyrin domain containing protein 3 | 606416 | 1q44 | Dominant | KEFH | Keratoendothelitis fugax hereditaria | 148200 | ||
NLRP3 | NLR pyrin domain containing protein 3 | 606416 | 1q44 | Dominant | MWS | Muckle-Wells Syndrome | 191900 | CAPS2 | CIAS1 associated periodic syndrome 2 |
NLRP7 | NLR pyrin domain containing protein 7 | 609661 | 19q13.42 | Recessive | HYDM1 | Hydatidiform Mole, Recurrent, 1 | 231090 | RHM HYDM CHM |
Recurrent hydatiform moles Hydatidiform mole Hydatidiform mole, complete Gestational trophoblastic disease |
NOD2 | Nucleotide-binding oligomerization domain 2 | 605956 | 16q12.1 | Dominant | BLAUS | Blau syndrome | 186580 | EOS | Sarcoidosis, Early-Onset JABS syndrome |
NOD2 | Nucleotide-binding oligomerization domain 2 | 605956 | 16q12.1 | Multifactorial | IBD1 | Inflammatory bowel disease 1 | 266600 | Crohn disease | |
OTULIN | OTU deubiquitinase with linear linkage specificity | 615712 | 5p15.2 | Recessive | AIPDS | AutoInflammation, Panniculitis, and Dermatosis Syndrome | 617099 | ORAS | OTULIN-Related Autoinflammatory Syndrome Otulipenia |
PLCG1 | Phospholipase C, Gamma-1 | 172420 | 20q12 | Dominant | IDAA | Immune Dysregulation, Autoimmunity, and Autoinflammation | 620514 | APLS | Activating PLCG1 variant-associated syndrome |
PLCG2 | Phospholipase C, Gamma-2 | 600220 | 16q23.3 | Dominant | APLAID | Autoinflammation, Antibody Deficiency, and Immune Dysregulation | 614878 | Autoinflammation, antibody deficiency, and immune dysregulation, PLCG2-associated | |
PLCG2 | Phospholipase C, Gamma-2 | 600220 | 16q23.3 | Dominant | FCAS3 | Familial Cold Autoinflammatory Syndrome 3 | 614468 | PLAID FACU |
Antibody Deficiency and Immune Dysregulation, PLCG2-associated Familial Atypical Cold Urticaria |
POMP | Proteasome maturation protein | 613386 | 13q12.3 | Dominant | PRAAS2 | Proteasome-associated autoinflammatory syndrome 2 | 618048 | ||
PSMA3 | Proteasome Subunit, Alpha-Type, 3 | 176843 | 14q23.1 | Recessive | CANDLE/PRASS | ||||
PSMB4 | Proteasome Subunit, Beta-Type, 4 | 602177 | 1q21.3 | Recessive | PRAAS3 | Proteasome-associated autoinflammatory syndrome 3 | 617591 | ||
*Gene name as approved by HUGO | **Disease name as approved by OMIM | ||||||||
<< Previous Next >> | Page 3 of 4 |